Tislelizumab in perioperative NSCLC: a step toward precision and practicality
1Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Chinese Clinical Oncology
|September 2, 2025
Abstract
No abstract available in PubMed .
Keywords:
Non-small cell lung cancer (NSCLC)adjuvant immunotherapyneoadjuvant immunotherapyperioperative immunotherapyMore Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.7K
